Skip to main content
Log in

PET Scans of Abdominal Malignancy

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract. Positron emission tomography (PET) with fluorine-18-2-d-deoxyglucose (FDG) currently is being integrated into clinical oncology because it provides unique functional information that can be applied to the management of cancer. In particular, it is useful for assessing tumor activity and growth, evaluating efficacy of therapy, and detecting tumor recurrence. Studies have demonstrated the value of whole-body PET-FDG imaging when staging and managing abdominal malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blahd, W., Brown, C., Khonsary, S. et al. PET Scans of Abdominal Malignancy. World J. Surg. 20, 245–247 (1996). https://doi.org/10.1007/s002689900039

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002689900039

Keywords

Navigation